Lithium Controlled-Release and Extended-Release Tablets and Palifermin Intravenous
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Palifermin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: palifermin
Brand name: Kepivance
Synonyms: Palifermin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Paliperidone
- Lithium Controlled-Release and Extended-Release Tablets-Paliperidone Extended-Release Tablets
- Lithium Controlled-Release and Extended-Release Tablets-Paliperidone injection
- Lithium Controlled-Release and Extended-Release Tablets-Paliperidone Intramuscular
- Lithium Controlled-Release and Extended-Release Tablets-Palladone
- Lithium Controlled-Release and Extended-Release Tablets-Palmitate-A
- Palifermin Intravenous-Lithium ER
- Palifermin Intravenous-Lithium Oral Solution
- Palifermin Intravenous-Lithium Salts
- Palifermin Intravenous-Lithium Syrup and Oral Solution
- Palifermin Intravenous-Lithobid
- Palifermin Intravenous-Lithostat